Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ark Genomic Revolution ETF (ARKG)

Ark Genomic Revolution ETF (ARKG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Ark Funds
  • Assets Under Management 2,979,224,600
  • Market Capitalization, $K 2,979,225
  • Shares Outstanding, K 41,955
  • 60-Month Beta 1.65
Trade ARKG with:
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 2.11 (2.97%)
  • Most Recent Dividend 2.108 on 12/27/19
  • Management Fee 0.75%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.91 +8.63%
on 09/29/20
76.22 -10.34%
on 10/14/20
+5.19 (+8.22%)
since 09/28/20
3-Month
52.80 +29.43%
on 09/04/20
76.22 -10.34%
on 10/14/20
+14.29 (+26.44%)
since 07/28/20
52-Week
24.00 +184.75%
on 03/18/20
76.22 -10.34%
on 10/14/20
+38.88 (+131.98%)
since 10/28/19

Most Recent Stories

More News
3 ETFs That Could SOAR Into 2021

There's a good chance that the market keeps trending higher in 2020. We have a dovish Fed, an economic recovery, and some meaningful signs that manufacturing is going to start picking up momentum. ARKG,...

SPY : 328.59 (-2.85%)
XLB : 62.00 (-2.73%)
ARKG : 68.38 (-3.76%)
PEJ : 30.21 (-2.86%)
4 Sector ETFs That Have Doubled This Year

Few sector ETFs have doubled this year amid the coronavirus pandemic.

TAN : 68.50 (+0.34%)
ARKW : 115.04 (-2.67%)
ARKG : 68.38 (-3.76%)
XVZ : 43.30 (+5.25%)
4 Innovative ETFs to SUPERPOWER Your Portfolio in 2021

ARK Innovation ETF (ARKK), ARK Genomic Revolution ETF (ARKG), ARK Web x.0 ETF (ARKW) and Renaissance IPO ETF (IPO) are outperforming the broader market and are setting up to offer intriguing upside in...

ARKK : 95.46 (-3.21%)
ARKG : 68.38 (-3.76%)
ARKW : 115.04 (-2.67%)
IPO : 52.57 (-2.81%)
Why You Should Invest in Genomics ETFs

Genomics ETFs have surged of late; here's why

REGN : 567.83 (-2.52%)
GILD : 58.26 (-2.92%)
NVTA : 44.74 (-7.04%)
CRSP : 94.93 (-3.25%)
ARKG : 68.38 (-3.76%)
GNOM : 18.53 (-3.29%)
IDNA : 38.89 (-2.75%)
Biotech ETFs to Shine on Coronavirus Antibodies Progress

With Regeneron Pharmaceuticals and Eli Lilly & Company requesting the FDA for an Emergency Use Authorization for their antibody therapy treatments, the biotech space is filled with optimism.

IBB : 132.75 (-2.30%)
XBI : 114.39 (-2.59%)
BBH : 155.19 (-2.65%)
PBE : 57.85 (-2.90%)
ARKG : 68.38 (-3.76%)
5 Sector ETFs Gaining in Double Digits to Start October

Wall Street registered back-to-back weekly gains primarily on the back of prospects for another round of fiscal stimulus from Congress.

TAN : 68.50 (+0.34%)
REMX : 40.14 (-2.17%)
MLPO : 6.47 (-2.28%)
ARKG : 68.38 (-3.76%)
THCX : 8.80 (-2.87%)
Genomics ETFs Surge on Nobel Prize for Gene-Editing Pioneers

The announcement of the 2020 Nobel Prize winners for Chemistry has successfully brought investor attention to the gene-editing space.

PBE : 57.85 (-2.90%)
ARKG : 68.38 (-3.76%)
GNOM : 18.53 (-3.29%)
IDNA : 38.89 (-2.75%)
Biotech ETFs to Gain on Trump's COVID-19 Treatment Protocol

The progress in Trump's health condition and his treatment protocols are continuously under the purview of market participants and are impacting Wall Street movements.

IBB : 132.75 (-2.30%)
XBI : 114.39 (-2.59%)
BBH : 155.19 (-2.65%)
PBE : 57.85 (-2.90%)
ARKG : 68.38 (-3.76%)
Healthcare ETFs Pop on Bristol Myers-MyoKardia Deal

These funds could be the best ways for investors to tap the opportunity arising from the Bristol Myers-MyoKardia deal and will likely see smooth trading in the months to come.

BMY : 57.77 (-1.65%)
XBI : 114.39 (-2.59%)
XPH : 44.03 (-2.70%)
BBC : 39.49 (-3.45%)
SBIO : 43.74 (-3.21%)
MYOK : 222.92 (unch)
ARKG : 68.38 (-3.76%)
Top-Performing Biotech ETFs Amid the Coronavirus Crisis

The race to introduce vaccine and treatment of coronavirus is opening up opportunities, making the biotech sector a prospective space for investments.

IBB : 132.75 (-2.30%)
XBI : 114.39 (-2.59%)
BBH : 155.19 (-2.65%)
ARKG : 68.38 (-3.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The ARK Genomic Revolution ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials,...

See More

Top 10 Holdings

Name % Holdings
CRISPR THERAPEUTICS AG 9.33%
Invitae Corp 8.54%
ILLUMINA INC 8.31%
Compugen Ltd 7.32%
ARCTURUS THERAPEUTICS HOLDIN 6.38%
Intellia Therapeutics Inc 5.13%
Iovance Biotherapeutics Inc 4.08%
EDITAS MEDICIN 3.66%
CareDx Inc 3.54%
Cellectis SA 3.33%

See More

Key Turning Points

2nd Resistance Point 72.51
1st Resistance Point 71.78
Last Price 68.46
1st Support Level 69.84
2nd Support Level 68.64

See More

52-Week High 76.22
Last Price 68.46
Fibonacci 61.8% 56.27
Fibonacci 50% 50.11
Fibonacci 38.2% 43.95
52-Week Low 24.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar